m+Medelevator.RU
← Поиск публикаций
Clinical research in cardiology : official journal of the German Cardiac Society · 2022

Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2.

Клиническое исследованиеСтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mavromanoli Anna C, Barco Stefano, Ageno Walter, Bouvaist Hélène, Brodmann Marianne, Cuccia Claudio, Couturaud Francis, Dellas Claudia, Dimopoulos Konstantinos, Duerschmied Daniel, Empen Klaus, Faggiano Pompilio, Ferrari Emile, Galiè Nazzareno, Galvani Marcello, Ghuysen Alexandre, Giannakoulas George, Huisman Menno V, Jiménez David, Kozak Matija, Lang Irene M, Meneveau Nicolas, Münzel Thomas, Palazzini Massimiliano, Petris Antoniu Octavian, Piovaccari Giancarlo, Salvi Aldo, Schellong Sebastian, Schmidt Kai-Helge, Verschuren Franck, Schmidtmann Irene, Toenges Gerrit, Klok Frederikus A, Konstantinides Stavros V, PEITHO-2 Investigators

Аннотация

BACKGROUND: Right ventricular (RV) function plays a critical role in the pathophysiology and acute prognosis of pulmonary embolism (PE). We analyzed the temporal changes of RV function in the cohort of a prospective multicentre study investigating if an early switch to oral anticoagulation in patients with intermediate-risk PE is effective and safe.

METHODS: Echocardiographic and laboratory examinations were performed at baseline (PE diagnosis), 6 days and 6 months. Echocardiographic parameters were classified into categories representing RV size, RV free wall/tricuspid annulus motion, RV pressure overload and right atrial (RA)/central venous pressure.

RESULTS: RV dysfunction based on any abnormal echocardiographic parameter was present in 84% of patients at baseline. RV dilatation was the most frequently abnormal finding (40.6%), followed by increased RA/central venous pressure (34.6%), RV pressure overload (32.1%), and reduced RV free wall/tricuspid annulus motion (20.9%). As early as day 6, RV size remained normal or improved in 260 patients (64.7%), RV free wall/tricuspid annulus motion in 301 (74.9%), RV pressure overload in 297 (73.9%), and RA/central venous pressure in 254 (63.2%). At day 180, the frequencies slightly increased. The median NT-proBNP level decreased from 1448 pg/ml at baseline to 256.5 on day 6 and 127 on day 180.

CONCLUSION: In the majority of patients with acute intermediate-risk PE switched early to a direct oral anticoagulant, echocardiographic parameters of RV function normalised within 6 days and remained normal throughout the first 6 months. Almost one in four patients, however, continued to have evidence of RV dysfunction over the long term.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты